Analyzing Pregnancy Costs with Finite Mixture Models: An Opportunity to More Adequately Accommodate the Presenceof Patient Data Heterogeneity
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2015, Vol 2, Issue 3
Abstract
The choice of a model in the analysis of patient health care costs and utilization is critical for a clear understanding of the behavior and estimation of quantities like incremental costs or cost-effectiveness. In studying heath care claims related to pregnancy, it would not be surprising that a small portion of the women have costs associated with their care and treatment that might be extreme or outlying. Many strategies exist for accommodating outliers; however, is one approach superior to the others because it may be implemented over a broader set of conditions without making unreasonable assumptions about the prevailing data characteristics? In this study, the author will show an example of a data set based on the medical claims for over 300K pregnant women, aged 15-49, where the traditional, or widely used Generalized Linear Model (GLM) approach to modeling costs may be less than optimal due to the presence of patients with very large, or very small expenditure values. These values, in some sense “contaminate” the typically employed GLM and cause it to violate its underlying requisite statistical assumptions. Finite Mixture Models (FMMs) have been employed in other areas of clinical research to model health care utilization. The author will introduce FMMs as an alternative to the commonly used GLM model and show that in his example data set, the fit of the FMMs is superior for the modeling of maternity expenditures in the presence of extreme or outlying cost values.
Authors and Affiliations
Paul Juneau
Keywords
Related Articles
- EP ID EP553555
- DOI 10.17140/GOROJ-2-115
- Views 175
- Downloads 0
A Novel Contributor to Endometrial Receptivity: Endometrial Microbiota
In the recent years, our knowledge about human reproductive system has increased with the development of assisted reproductive technologies; however, embryo implantation rate is still around 25-30%.1 Embryo implantation...
Human Placentas and the Changing Face of Reproductive Toxicology Testing
Pharmaceuticals are in use by 40-98% of pregnant mothers in the developed world, varying by country. There is a significant potential for obstetricians to further maintain medical prescriptions for chronic diseases durin...
Competing Endoscopic Surgeries in the Era of Assisted Reproductive Technologies: Evidence and Practice
Now-a-days the assisted reproductive technologies (ART) are progressing and advancing rapidly. Many reproductive medicine specialists do believe in ART to be the first choice for infertile women regardless of age related...
Post-Operative Outcomes of Oxidized Regenerated Cellulose Use in Women Undergoing Cesarean Delivery
Introduction: In spite of careful technique, bleeding may continue to occur at time of surgery. Absorbable hemostatic agents have been developed in order to control hemorrhage. However, no study to date has investigated...
Hyperuricemia as a Predictor of Perinatal Outcomes in Pregnancy Induced Hypertension
Aim/Objective The aim of this study to determine the relationship between hyperuricemia and perinatal outcome in pregnancy induced hypertension. Material & Methods This prospective and observational study was carried out...